scholarly article | Q13442814 |
P2093 | author name string | Liping Yang | |
Kaiyao Shi | |||
Fanbo Meng | |||
Daoyuan Si | |||
Dongna Liu | |||
Yushuang Yang | |||
Heyu Meng | |||
P2860 | cites work | The Global Burden of Ischemic Heart Disease in 1990 and 2010: The Global Burden of Disease 2010 Study | Q22241915 |
Gene Expression Signatures of Coronary Heart Disease | Q24289001 | ||
Mammalian long-chain acyl-CoA synthetases | Q24602470 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
Genomewide association studies in cardiovascular disease--an update 2011 | Q28254212 | ||
Acyl coenzyme a synthetase regulation: putative role in long-chain acyl coenzyme a partitioning | Q28565954 | ||
Overexpression of rat long chain acyl-coa synthetase 1 alters fatty acid metabolism in rat primary hepatocytes | Q28580665 | ||
ACSL1 Is Associated With Fetal Programming of Insulin Sensitivity and Cellular Lipid Content | Q33631697 | ||
Acyl-CoA synthesis, lipid metabolism and lipotoxicity. | Q33665741 | ||
Physiological and nutritional regulation of enzymes of triacylglycerol synthesis | Q34001422 | ||
Adipose acyl-CoA synthetase-1 directs fatty acids toward beta-oxidation and is required for cold thermogenesis | Q34021724 | ||
Prostaglandins and inflammation | Q34179727 | ||
Genome-Wide Association Study of Coronary Artery Disease | Q34218772 | ||
Third universal definition of myocardial infarction | Q34295914 | ||
Overexpressed FATP1, ACSVL4/FATP4 and ACSL1 increase the cellular fatty acid uptake of 3T3-L1 adipocytes but are localized on intracellular membranes | Q34425240 | ||
Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: an update | Q35221773 | ||
Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. | Q35849515 | ||
Measuring the global burden of disease and epidemiological transitions: 2002-2030. | Q36561190 | ||
Mechanisms of disease: The genetic basis of coronary heart disease. | Q36950890 | ||
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators. | Q38059912 | ||
Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease | Q38265002 | ||
Gene Expression Signatures and the Spectrum of Coronary Artery Disease | Q38531858 | ||
Acyl-CoA synthetase 1 is required for oleate and linoleate mediated inhibition of cholesterol efflux through ATP-binding cassette transporter A1 in macrophages | Q39454322 | ||
Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo | Q40279185 | ||
Peak and fixed-time high-sensitive troponin for prediction of infarct size, impaired left ventricular function, and adverse outcomes in patients with first ST-segment elevation myocardial infarction receiving percutaneous coronary intervention | Q47250321 | ||
Youden's index and the weight of evidence | Q47407239 | ||
Genetic susceptibility of myocardial infarction. | Q51720570 | ||
Acute myocardial infarction | Q54069247 | ||
Diagnostic marker cooperative study for the diagnosis of myocardial infarction | Q77222242 | ||
Extensive serum biomarker analysis in patients with ST segment elevation myocardial infarction (STEMI) | Q85553865 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 4065-4072 | |
P577 | publication date | 2017-09-01 | |
P1433 | published in | Experimental and Therapeutic Medicine | Q23979083 |
P1476 | title | High expression of long chain acyl-coenzyme A synthetase 1 in peripheral blood may be a molecular marker for assessing the risk of acute myocardial infarction | |
P478 | volume | 14 |
Search more.